Chancery Grants Class $3M In Legal Fees For Sorrento Suit
A Delaware vice chancellor approved a $3.25 million settlement fee Tuesday for class attorneys who sued biopharma Sorrento Therapeutics Inc. in 2016 over insider stock and option awards and conflicted asset...To view the full article, register now.
Already a subscriber? Click here to view full article